Indefinite Delivery Contract 75F40126D00015
- Not listed
- The Food and Drug Administration awarded a $19.9 million Blanket Purchase Agreement to AB Sciex LLC, a division of Danaher Corporation, on September 24, 2024, with an ultimate completion date of April 25, 2025. This single-award, no-set-aside contract is established under the General Services Administration's Multiple Award Schedule and authorizes AB Sciex LLC to supply triple quadrupole mass spectrometers, high-performance liquid chromatography systems, ultra-high-performance liquid...
- The U.S. Food and Drug Administration (FDA) has awarded a $1 million single-award Indefinite Delivery, Indefinite Quantity (IDIQ) contract to Pacific Biosciences of California, Inc. to provide sequencing reagents, kits, and consumables to support the agency's genomic research and regulatory review activities. Under this contract, the FDA has issued multiple delivery orders for the purchase of Pacific Biosciences' proprietary single molecule, real-time (SMRT) sequencing consumables, including...
- The Food and Drug Administration awarded a Total Small Business set-aside indefinite-delivery contract to American Biomedical Group Inc. with a ceiling of $0.00 and an ultimate completion date of September 24, 2022, effective September 25, 2017. Work encompasses scientific computing instrument maintenance and repair services performed across multiple FDA facilities in Maryland, including Silver Spring, Rockville, Berwyn Heights, and Laurel. The IDIQ is a single-award vehicle structured to...
- The Food and Drug Administration awarded a single-award indefinite-delivery contract to Mpza LLC, a minority-owned and women-owned small business, on May 26, 2023, with a $40 million ceiling for FDA Adverse Event Reporting System (FAERS) Data Management Program Support Services under a Total Small Business set-aside. The contract extends through May 24, 2028. Place of performance is Silver Spring, Maryland. The IDIQ supports FDA's operations in processing, managing, and analyzing adverse event...
- The Department of Health and Human Services Food and Drug Administration (FDA) awarded a single-award Indefinite Delivery Contract (IDC) to AB Sciex LLC, a division of Danaher Corporation, for a 5-year maintenance and service contract for liquid chromatography-tandem mass spectrometers (LC-MS/MS). The contract has a ceiling value of $2,503,000 and a period of performance through April 23, 2029. Under this IDC, the FDA awarded a $225,566.45 Firm Fixed Price Delivery Order to AB Sciex LLC for an...
- The Food and Drug Administration awarded a single-award Indefinite Delivery Contract to Illumina, Inc. on November 28, 2022, with a ceiling of $25 million for Illumina reagent chemistry kits, with an ultimate completion date of January 29, 2028. Place of performance encompasses multiple FDA facilities across the United States, including Silver Spring, Maryland; Laurel, Maryland; Berwyn Heights, Maryland; Irvine, California; Alameda, California; Bothell, Washington; Jamaica, New York; Everett,...
- This Blanket Purchase Agreement, awarded by the Food and Drug Administration (FDA) on September 19, 2022, to Agilent Technologies Inc. (Customer Service and Sales Division), establishes a single-award, competitively procured contract vehicle with a ceiling value of $9.95 million and a performance period extending through September 19, 2027. The contract covers the procurement of Inductively Coupled Plasma Mass Spectrometers (ICP-MS) systems with optional High-Performance Liquid Chromatography...
- The Food and Drug Administration awarded an indefinite-delivery contract to Vets Synergetic Group LLC, an SBA 8(a) Joint Venture and minority-owned small disadvantaged business, on June 4, 2024, with a ceiling value of $99.883 million and a completion date of June 9, 2028. This is a single-award, Competitive 8(a) set-aside vehicle designated the FDA Scientific Support IDIQ. Place of performance spans multiple FDA facilities including Silver Spring, Maryland; Leesburg, Virginia; Berwyn Heights,...
- The Food and Drug Administration awarded an indefinite-delivery contract to Denver Health and Hospital Authority for non-medical use surveillance data reporting and analysis services, with a contract ceiling of $8.5 million and an award date of September 30, 2026. This is a multiple-award IDIQ; the FDA anticipated awarding a maximum of two contracts under the same solicitation. Place of performance is Silver Spring, Maryland. The contract supports post-marketing surveillance data collection...
- The Food and Drug Administration awarded a Total Small Business single-award IDIQ to Amtis-Heitech, LLC on March 19, 2015, with a ceiling of $103 million and an ultimate completion date of September 30, 2020. The contract is for fully integrated records facility and offsite document control center services. Place of performance is Rockville, Maryland, with work also performed in Hyattsville and Silver Spring, Maryland. The IDIQ has supported FDA operations across multiple centers and offices...
The Food and Drug Administration awarded a single-award indefinite-delivery contract to Axion Biosystems, Inc. on August 17, 2026, for consumables (multi-well plates) for use in multielectrode array (MEA) systems, with a contract ceiling of $600,000.00 and ultimate completion date of August 16, 2031. The contract requires supply of 12-, 48-, and 96-well plate configurations compatible with Axion Biosystems MEA systems, including specific models M768-tMEA-96W, M768-tMEA-48W, and M768-tMEA-48OPT. Plates must feature a minimum of 700 electrodes per plate and support real-time well-by-well signal review, adjustable filters, temperature and electrical stimulation control, automatic cardiac and neural network identification, and measurement of field potential duration, beat period, conduction velocity, spike amplitude, viability, firing rate, and burst characteristics for microphysiological studies using human induced pluripotent stem cells. The period of performance runs from July 31, 2026, through July 30, 2027 (base year) plus four option years, extending through August 16, 2031. Delivery occurs within 30 days of order placement to the FDA Center for Drug Evaluation and Research in Silver Spring, Maryland. The FDA's Office of Acquisition and Grant Services issued the originating pre-solicitation on May 27, 2026, with capability statements due June 3, 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 8/16/26 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
IDIQ for the purchase of consumables (multi-well plates) for use in Axion Biosystems Multielectrode Array systems | 75F40126SSN133126 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Pre-Solicitation 1/2 | 5/27/26, 4:42 PM | |
IDIQ for the purchase of consumables (multi-well plates) for use in Axion Biosystems Multielectrode Array systems | 75F40126Q133126 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 2/2 | 7/6/26, 11:18 AM |